CASI
CASI Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
4.00 / 10
Netural
Fund flow evaluation shows a robust 6.99/10, indicating strong money inflow despite adverse overall trends. Analyst consensus is overwhelmingly bullish (1 Strong Buy, 0 others), yet the historical win rate is low, adding uncertainty to the outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-03
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate0.0%
Is money flowing into or out of CASI?
- CASI holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.00/10 (Netural).
